Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Oncologists must act to manage cancer detected through prenatal screening

    The ability of prenatal cell-free DNA sequencing to incidentally detect occult maternal malignancies was first documented over a decade ago, yet coordinated follow-up of pregnant people who receive these resul...

    Amy E. Turriff, Diana W. Bianchi in Nature Reviews Cancer (2024)

  2. No Access

    Article

    The All of Us Research Program is an opportunity to enhance the diversity of US biomedical research

    The All of Us Research Program has prioritized the enrollment of people from backgrounds that are historically under-represented in medical research to bring precision medicine to the full diversity of the US ...

    Diana W. Bianchi, Patricia Flatley Brennan, Michael F. Chiang in Nature Medicine (2024)

  3. No Access

    Chapter

    Maternal Secondary Genomic Findings Detected by Fetal Genetic Testing

    Prenatal sequencing to noninvasively screen for fetal aneuploidies is performed on a mixed DNA sample containing maternal and placental DNA fragments. Therefore, genomic abnormalities originating in the matern...

    Amy Turriff, Diana W. Bianchi in Prenatal Diagnostic Testing for Genetic Disorders (2023)

  4. No Access

    Article

    Down syndrome

    Trisomy 21, the presence of a supernumerary chromosome 21, results in a collection of clinical features commonly known as Down syndrome (DS). DS is among the most genetically complex of the conditions that are...

    Stylianos E. Antonarakis, Brian G. Skotko in Nature Reviews Disease Primers (2020)

  5. No Access

    Article

    The power of human touch in the era of artificial intelligence

    Diana W. Bianchi in Pediatric Research (2019)

  6. Article

    Open Access

    An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome

    Anatomical and functional brain abnormalities begin during fetal life in Down syndrome (DS). We hypothesize that novel prenatal treatments can be identified by targeting signaling pathways that are consistentl...

    Faycal Guedj, Jeroen LA Pennings, Lauren J. Massingham in Scientific Reports (2016)

  7. Article

    Open Access

    Gene expression in term placentas is regulated more by spinal or epidural anesthesia than by late-onset preeclampsia or gestational diabetes mellitus

    Pre-eclampsia (PE) and gestational diabetes mellitus (GDM) are common complications of pregnancy, but the mechanisms underlying these disorders remain unclear. The aim was to identify the extent of altered gen...

    Tove Lekva, Robert Lyle, Marie Cecilie Paasche Roland, Camilla Friis in Scientific Reports (2016)

  8. Article

    Pregnancy: Prepare for unexpected prenatal test results

    Women are learning about their own health problems through fetal screening. Revise consent forms and raise awareness, urges Diana W. Bianchi.

    Diana W. Bianchi in Nature (2015)

  9. No Access

    Article

    Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome

    Turner syndrome is a sex chromosome aneuploidy with characteristic malformations. Amniotic fluid, a complex biological material, could contribute to the understanding of Turner syndrome pathogenesis. In this p...

    Lauren J. Massingham, Kirby L. Johnson, Thomas M. Scholl, Donna K. Slonim in Human Genetics (2014)

  10. Article

    Open Access

    DFLAT: functional annotation for human development

    Recent increases in genomic studies of the develo** human fetus and neonate have led to a need for widespread characterization of the functional roles of genes at different developmental stages. The Gene Ont...

    Heather C Wick, Harold Drabkin, Huy Ngu, Michael Sackman in BMC Bioinformatics (2014)

  11. No Access

    Chapter and Conference Paper

    CSAX: Characterizing Systematic Anomalies in eXpression Data

    Methods for translating gene expression signatures into clinically relevant information have typically relied upon having many samples from patients with similar molecular phenotypes. Here, we address the ques...

    Keith Noto, Carla Brodley, Saeed Majidi in Research in Computational Molecular Biology (2014)

  12. No Access

    Article

    Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21

    Trisomies 18 and 21 are the two most common live born autosomal aneuploidies in humans. While the anatomic abnormalities in affected fetuses are well documented, the dysregulated biological pathways associated...

    Lisa Hui, Donna K. Slonim, Heather C. Wick, Kirby L. Johnson, Keiko Koide in Human Genetics (2012)

  13. No Access

    Article

    Fetal genes in mother's blood

    The genome sequence of a fetus can be inferred from the relative numbers of variants of DNA sequences in a pregnant woman's blood. This advance in non-invasive diagnostics comes with some ramifications. See Artic...

    Diana W. Bianchi in Nature (2012)

  14. No Access

    Article

    From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges

    Genomic technologies are being rapidly applied to the area of prenatal diagnosis, and many genomic prenatal tests have already been transitioned to the clinic. Diana Bianchi reviews these advances in prentatal...

    Diana W Bianchi in Nature Medicine (2012)

  15. Article

    Open Access

    Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study

    Studies have shown that fetal progenitor cells persist in maternal blood or bone marrow for more than 30 years after delivery. Increased trafficking of fetal cells occurs during pregnancy complications, such a...

    Linda van Wyk, Jacolien van der Marel in Arthritis Research & Therapy (2011)

  16. No Access

    Article

    Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18

    Trisomy 18 is a common human aneuploidy that is associated with significant perinatal mortality. Unlike the well-characterized “critical region” in trisomy 21 (21q22), there is no corresponding region on chrom...

    Keiko Koide, Donna K. Slonim, Kirby L. Johnson, Umadevi Tantravahi in Human Genetics (2011)

  17. No Access

    Chapter and Conference Paper

    A “Fluid-Agnostic” Approach to Analysis of Fetal and Neonatal Developmental Gene Expression

    To date, most research on fetal nucleic acid trafficking in the maternal circulation has largely concentrated on noninvasive prenatal diagnosis of trisomy 21 and single gene disorders using circulating cell-fr...

    Jill L. Maron, Diana W. Bianchi in Circulating Nucleic Acids in Plasma and Serum (2011)

  18. No Access

    Article

    Microchimerism in Endocrine Pathology

    Chimerism in an individual refers to the coexistence of cells arising from two distinct organisms. It can arise iatrogenically via transplant or blood transfusion, and physiologically via twin to twin transfer, o...

    Daniel W. Rust, Diana W. Bianchi in Endocrine Pathology (2009)

  19. No Access

    Protocol

    Method for Extraction of High-Quantity and -Quality Cell-Free DNA from Amniotic Fluid

    Circulating cell-free fetal deoxyribonucleic acids (cffDNAs) are promising biomarkers with various potential clinical applications. Second and third trimester amniotic fluid (AF) is a rich source of cffDNAs. F...

    Olav Lapaire, Kirby L. Johnson, Diana W. Bianchi in Prenatal Diagnosis (2008)

  20. No Access

    Article

    Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18

    Cell-free fetal DNA in the maternal circulation is a potential noninvasive marker for fetal aneuploidies. In previous studies with Y DNA as a fetal-specific marker, levels of circulating fetal DNA were shown ...

    Tuangsit Wataganara, Erik S. LeShane, Antonio Farina in Human Genetics (2003)

previous disabled Page of 2